| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CRACR2A PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRIN1 EFHB ZZEF1 F9 DST RASGRP3 HRC ATP2A2 RHOT1 | 7.94e-07 | 749 | 136 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.06e-06 | 5 | 136 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP13A1 KIF1B RSF1 MCM6 RAD54L2 KIF3B IQCA1 CCT8 ATP11C ATP2A2 DNAH8 | 2.21e-04 | 441 | 136 | 11 | GO:0016887 |
| GeneOntologyBiologicalProcess | transport along microtubule | BICDL2 KIF1B AGBL4 KIF3B DST SUN2 RPGR SPAG17 HSPB1 SOD1 RHOT1 | 7.28e-08 | 197 | 135 | 11 | GO:0010970 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | BICDL2 KIF1B AGBL4 KIF3B DST SUN2 RPGR SPAG17 HSPB1 SOD1 RHOT1 | 2.79e-07 | 225 | 135 | 11 | GO:0030705 |
| GeneOntologyBiologicalProcess | microtubule-based transport | BICDL2 KIF1B AGBL4 KIF3B DST SUN2 RPGR SPAG17 HSPB1 SOD1 RHOT1 | 8.93e-07 | 253 | 135 | 11 | GO:0099111 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.00e-06 | 187 | 135 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | axonal transport | 9.78e-06 | 75 | 135 | 6 | GO:0098930 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 1.68e-05 | 24 | 135 | 4 | GO:0008090 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICDL2 KIZ KIF1B CKAP5 C10orf90 KIAA1614 AGBL4 KIF3B DST IQCA1 SUN2 CC2D2A RPGR SPAG17 GPSM1 CFAP69 DNAH8 HSPB1 SOD1 RHOT1 | 1.83e-05 | 1058 | 135 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule-based movement | BICDL2 KIF1B AGBL4 KIF3B DST SUN2 RPGR SPAG17 CFAP69 DNAH8 HSPB1 SOD1 RHOT1 | 2.19e-05 | 493 | 135 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | aspartate metabolic process | 2.24e-05 | 9 | 135 | 3 | GO:0006531 | |
| GeneOntologyBiologicalProcess | anterograde axonal transport | 2.98e-05 | 55 | 135 | 5 | GO:0008089 | |
| GeneOntologyBiologicalProcess | organelle transport along microtubule | 4.27e-05 | 97 | 135 | 6 | GO:0072384 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 4.52e-05 | 98 | 135 | 6 | GO:0008088 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 8.79e-05 | 36 | 135 | 4 | GO:0007274 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid metabolic process | 9.07e-05 | 111 | 135 | 6 | GO:0043648 | |
| GeneOntologyBiologicalProcess | nuclear matrix anchoring at nuclear membrane | 1.27e-04 | 3 | 135 | 2 | GO:0090292 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.23e-04 | 313 | 135 | 9 | GO:0098742 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 ATP13A1 NT5E CP GRIN1 CCDC115 ITGAV INPP4B BSND HRC FTO ATP2A2 SOD1 | 2.27e-04 | 622 | 135 | 13 | GO:0098771 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 2.53e-04 | 4 | 135 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | acetate metabolic process | 2.53e-04 | 4 | 135 | 2 | GO:0006083 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 6.47e-07 | 110 | 137 | 8 | GO:0120111 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | KIF1B CKAP5 EFHB ADA AGBL4 KIF3B DST SPAG17 CFAP69 DNAH8 HSPB1 SOD1 | 1.23e-06 | 317 | 137 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | cytoplasmic region | KIF1B CKAP5 EFHB ADA AGBL4 KIF3B DST SPAG17 CFAP69 DNAH8 HSPB1 SOD1 | 4.58e-06 | 360 | 137 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | axon cytoplasm | 5.57e-06 | 68 | 137 | 6 | GO:1904115 | |
| GeneOntologyCellularComponent | manchette | 3.20e-05 | 28 | 137 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | axonemal central apparatus | 6.29e-04 | 6 | 137 | 2 | GO:1990716 | |
| MousePheno | ectopic manchette | 1.64e-05 | 19 | 117 | 4 | MP:0009377 | |
| MousePheno | abnormal manchette morphology | 3.52e-05 | 45 | 117 | 5 | MP:0009376 | |
| Domain | Cadherin_tail | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.03e-12 | 37 | 134 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.03e-12 | 37 | 134 | 9 | IPR031904 |
| Domain | Cadherin_2 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.74e-10 | 65 | 134 | 9 | PF08266 |
| Domain | Cadherin_N | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.74e-10 | 65 | 134 | 9 | IPR013164 |
| Domain | Cadherin_CS | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.94e-08 | 109 | 134 | 9 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.22e-07 | 113 | 134 | 9 | PS00232 |
| Domain | Cadherin | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.22e-07 | 113 | 134 | 9 | PF00028 |
| Domain | CADHERIN_2 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.32e-07 | 114 | 134 | 9 | PS50268 |
| Domain | - | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.32e-07 | 114 | 134 | 9 | 2.60.40.60 |
| Domain | CA | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.42e-07 | 115 | 134 | 9 | SM00112 |
| Domain | Cadherin-like | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.53e-07 | 116 | 134 | 9 | IPR015919 |
| Domain | Cadherin | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.78e-07 | 118 | 134 | 9 | IPR002126 |
| Domain | SOD_Cu_Zn_dom | 1.53e-04 | 3 | 134 | 2 | IPR001424 | |
| Domain | SOD_CU_ZN_2 | 1.53e-04 | 3 | 134 | 2 | PS00332 | |
| Domain | SOD_CU_ZN_1 | 1.53e-04 | 3 | 134 | 2 | PS00087 | |
| Domain | SOD_Cu/Zn_/chaperone | 1.53e-04 | 3 | 134 | 2 | IPR024134 | |
| Domain | SOD_Cu/Zn_BS | 1.53e-04 | 3 | 134 | 2 | IPR018152 | |
| Domain | Sod_Cu | 1.53e-04 | 3 | 134 | 2 | PF00080 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 2.60.40.200 | |
| Domain | EFh | 9.82e-04 | 158 | 134 | 6 | SM00054 | |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.81e-19 | 15 | 139 | 9 | 15640798 | |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.73e-18 | 17 | 139 | 9 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.43e-18 | 18 | 139 | 9 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.43e-18 | 18 | 139 | 9 | 10662547 |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.49e-16 | 24 | 139 | 9 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.30e-15 | 28 | 139 | 9 | 15347688 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.53e-12 | 57 | 139 | 9 | 32633719 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 1.66e-12 | 11 | 139 | 6 | 9655502 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.80e-12 | 58 | 139 | 9 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.08e-12 | 68 | 139 | 9 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.38e-11 | 72 | 139 | 9 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.78e-11 | 74 | 139 | 9 | 10817752 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.01e-11 | 75 | 139 | 9 | 15372022 |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.56e-11 | 77 | 139 | 9 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.65e-11 | 80 | 139 | 9 | 10716726 |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 CP PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FTO | 3.89e-10 | 193 | 139 | 11 | 22589738 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 7.34e-10 | 12 | 139 | 5 | 10612399 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.33e-09 | 119 | 139 | 9 | 28625976 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | UIMC1 MTHFD2 ACLY SYNE1 U2SURP MCM6 GPATCH4 XRCC1 SBSN ARPC2 CSDE1 DST ASS1 CCT8 PPP1R9B C3 LIMCH1 HADHA ATP2A2 HSPB1 | 1.43e-09 | 949 | 139 | 20 | 36574265 |
| Pubmed | UIMC1 NCAPD3 ATP13A1 NT5E SYNE1 TASP1 CKAP5 GPATCH4 XRCC1 TRRAP CIT CASZ1 CSDE1 PAXBP1 DST GZF1 RBM19 SUN2 CCT8 LIMCH1 FUT8 ATP2A2 ILVBL EPB41L2 | 6.20e-09 | 1497 | 139 | 24 | 31527615 | |
| Pubmed | NT5E ACLY U2SURP KIF1B MCM6 GPATCH4 MED13L CIT ARPC2 PAXBP1 SUN2 ASS1 CNDP2 CCT8 LIMCH1 HADHA GMPPB ATP2A2 HSPB1 WWC1 SOD1 | 2.69e-08 | 1247 | 139 | 21 | 27684187 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACLY SYNE1 WDR81 PCDHA8 CP ZZEF1 ARPC2 ARHGAP1 NBAS DST CNDP2 CCT8 HADHA MYO15A SPAG17 ATP2A2 PCCB | 2.71e-08 | 807 | 139 | 17 | 30575818 |
| Pubmed | SLC12A6 DDAH1 ACLY SYNE1 KIF1B CKAP5 GRIN1 CIT ARPC2 CSDE1 AGBL4 DST CCT8 PPP1R9B LIMCH1 HADHA ATP2A2 MTDH HSPB1 EPB41L2 SOD1 RHOT1 | 6.01e-08 | 1431 | 139 | 22 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RASA3 ACLY U2SURP RSF1 CKAP5 MCM6 GPATCH4 TRRAP CSDE1 PCGF6 DST RBM19 ASS1 ZNF638 CCT8 GSDMA HADHA GMPPB ATP2A2 HSPB1 EPB41L2 | 1.06e-07 | 1353 | 139 | 21 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ACLY CKAP5 LAMB3 CIT ARPC2 CSDE1 ARHGAP1 DST RBM19 SUN2 ASS1 ZNF638 CCT8 GSDMA PPP1R9B C3 HADHA MTDH HSPB1 EPB41L2 | 1.49e-07 | 1257 | 139 | 20 | 36526897 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.49e-07 | 4 | 139 | 3 | 19091768 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SERPINB7 CKAP5 CP XRCC1 MED13L CIT YOD1 CROCC2 SUN2 ZNF638 CCT8 C3 CCS RBFOX2 RHOT1 | 2.68e-07 | 732 | 139 | 15 | 34732716 |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 6.21e-07 | 5 | 139 | 3 | 17855024 | |
| Pubmed | CKAP5 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA3 PCDHA2 PCDHA1 XRCC1 CSDE1 | 9.08e-07 | 329 | 139 | 10 | 17474147 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 NCAPD3 U2SURP CKAP5 GPATCH4 XRCC1 TRRAP CASZ1 PCGF6 PAXBP1 DST SUN2 ZNF638 HADHA ATP2A2 MTDH ILVBL HSPB1 RBFOX2 | 1.04e-06 | 1294 | 139 | 19 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UIMC1 ACLY U2SURP RSF1 CKAP5 GPATCH4 CSDE1 DST ZNF638 CCT8 PPP1R9B BOD1L1 MTDH PKN3 EPB41L2 SOD1 | 1.12e-06 | 934 | 139 | 16 | 33916271 |
| Pubmed | 1.13e-06 | 20 | 139 | 4 | 21689717 | ||
| Pubmed | SLC12A6 UIMC1 SYNE1 U2SURP RSF1 RAD54L2 INSYN2A ARPC2 DST CC2D2A PPP1R9B ATP11C BOD1L1 LIMCH1 HADHA SPAG17 CFAP69 ATP2A2 DNAH8 MTDH | 1.27e-06 | 1442 | 139 | 20 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACLY CKAP5 GPATCH4 ARPC2 CSDE1 ARHGAP1 PCGF6 RBM19 CCT8 PPP1R9B HADHA ATP2A2 PCCB MTDH | 1.35e-06 | 724 | 139 | 14 | 36232890 |
| Pubmed | DDAH1 MTHFD2 ACLY ADA ITGAV QPRT ASS1 HADHA ATP2A2 PCCB DNAH8 HSPB1 CCS SOD1 PDZD2 | 1.96e-06 | 859 | 139 | 15 | 31536960 | |
| Pubmed | 3.34e-06 | 222 | 139 | 8 | 35941108 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACLY SYNE1 U2SURP CKAP5 MCM6 XRCC1 TRRAP CIT ARPC2 DST ZNF638 CCT8 HADHA ATP2A2 MTDH EPB41L2 | 3.64e-06 | 1024 | 139 | 16 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCAPD3 ATP13A1 ACLY SYNE1 U2SURP CKAP5 MCM6 GPATCH4 ARPC2 PAXBP1 RBM19 CCT8 CC2D2A BOD1L1 HADHA ATP2A2 MTDH HSPB1 EPB41L2 | 4.25e-06 | 1425 | 139 | 19 | 30948266 |
| Pubmed | Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development. | 5.16e-06 | 9 | 139 | 3 | 29203794 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | UIMC1 NCAPD3 RSF1 CKAP5 LAMB3 ZNF407 ITGAV CASZ1 SBSN GZF1 SUN2 FUT8 ATP2A2 MTDH ILVBL HSPB1 SOD1 | 6.70e-06 | 1203 | 139 | 17 | 29180619 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 8.19e-06 | 179 | 139 | 7 | 36261009 | |
| Pubmed | ATP13A1 ACLY KBTBD8 TASP1 GPATCH4 ITGAV SBSN CSDE1 PAXBP1 GZF1 RBM19 CCT8 LIMCH1 HADHA MTDH HSPB1 EPB41L2 SOD1 | 9.59e-06 | 1371 | 139 | 18 | 36244648 | |
| Pubmed | 1.15e-05 | 538 | 139 | 11 | 28524877 | ||
| Pubmed | ACLY U2SURP RSF1 CKAP5 MCM6 TRRAP CSDE1 DST ZNF638 HADHA ATP2A2 EPB41L2 | 1.32e-05 | 653 | 139 | 12 | 22586326 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.43e-05 | 271 | 139 | 8 | 25737280 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDAH1 NT5E ACLY CP ITGAV ARPC2 ARHGAP1 KIF3B HPD ASS1 CNDP2 CCT8 MYO15A HSPB1 SOD1 | 1.46e-05 | 1016 | 139 | 15 | 19056867 |
| Pubmed | 1.47e-05 | 272 | 139 | 8 | 31010829 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16132821 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28973175 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17683925 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17368952 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18393442 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15337829 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3035575 | ||
| Pubmed | Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). | 1.59e-05 | 2 | 139 | 2 | 3498943 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15069187 | ||
| Pubmed | A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants. | 1.59e-05 | 2 | 139 | 2 | 29234142 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 1534146 | ||
| Pubmed | Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model. | 1.59e-05 | 2 | 139 | 2 | 25712859 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 1.59e-05 | 2 | 139 | 2 | 7889415 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3025647 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2452747 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9233619 | ||
| Pubmed | Stalk region of beta-chain enhances the coreceptor function of CD8. | 1.59e-05 | 2 | 139 | 2 | 12847256 | |
| Pubmed | Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q. | 1.59e-05 | 2 | 139 | 2 | 19227972 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28077719 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34069691 | ||
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 1.59e-05 | 2 | 139 | 2 | 8436166 | |
| Pubmed | Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. | 1.59e-05 | 2 | 139 | 2 | 18334481 | |
| Pubmed | Crystal structure of the second domain of the human copper chaperone for superoxide dismutase. | 1.59e-05 | 2 | 139 | 2 | 10677207 | |
| Pubmed | The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. | 1.59e-05 | 2 | 139 | 2 | 9726962 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3169881 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18307039 | ||
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 1.59e-05 | 2 | 139 | 2 | 7103930 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18552350 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12968068 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24363825 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19320055 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19335999 | ||
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 1.59e-05 | 2 | 139 | 2 | 5558567 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22869735 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16272960 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26511242 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12034498 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18337307 | ||
| Pubmed | Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. | 1.59e-05 | 2 | 139 | 2 | 8108731 | |
| Pubmed | Murine Ly-3 restriction fragment length polymorphism and transcript size differences. | 1.59e-05 | 2 | 139 | 2 | 2576243 | |
| Pubmed | In-cell NMR reveals potential precursor of toxic species from SOD1 fALS mutants. | 1.59e-05 | 2 | 139 | 2 | 25429517 | |
| Pubmed | Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. | 1.59e-05 | 2 | 139 | 2 | 11889469 | |
| Pubmed | The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. | 1.59e-05 | 2 | 139 | 2 | 9647223 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32121118 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21354101 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 408079 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30735496 | ||
| Pubmed | Characterization of the mouse CD8 beta chain-encoding gene promoter region. | 1.59e-05 | 2 | 139 | 2 | 8781121 | |
| Pubmed | SERPINB7 UIMC1 KIF1B CKAP5 LAMB3 XRCC1 LIMS3 INPP4B CSDE1 DST QPRT ZNF638 CCT8 C3 RPGR TNXB HSPB1 | 1.70e-05 | 1293 | 139 | 17 | 15342556 | |
| Pubmed | ACLY U2SURP GPATCH4 ITGAV TRRAP CSDE1 ARHGAP1 DST ASS1 CCT8 C3 BOD1L1 HADHA ATP2A2 ILVBL HSPB1 EPB41L2 | 1.77e-05 | 1297 | 139 | 17 | 33545068 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | SERPINB7 DDAH1 CCT8 CC2D2A GSDMA C3 HADHA MYO15A ATP2A2 HSPB1 SOD1 | 1.78e-05 | 564 | 139 | 11 | 21565611 |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 2.20e-05 | 14 | 139 | 3 | 17662146 | |
| Interaction | PCDHA10 interactions | 1.03e-12 | 22 | 136 | 8 | int:PCDHA10 | |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FUT8 | 1.09e-10 | 55 | 136 | 9 | int:PCDHA8 |
| Interaction | PCDHA7 interactions | 2.48e-08 | 14 | 136 | 5 | int:PCDHA7 | |
| Interaction | PCDHA1 interactions | 2.44e-07 | 9 | 136 | 4 | int:PCDHA1 | |
| Interaction | PCDHA11 interactions | 7.11e-06 | 19 | 136 | 4 | int:PCDHA11 | |
| Interaction | PCDHA6 interactions | 2.45e-05 | 9 | 136 | 3 | int:PCDHA6 | |
| Interaction | GOT1 interactions | 2.50e-05 | 286 | 136 | 10 | int:GOT1 | |
| Interaction | KIFBP interactions | 3.09e-05 | 180 | 136 | 8 | int:KIFBP | |
| Interaction | EED interactions | NCAPD3 ACLY CKAP5 MCM6 XRCC1 TRRAP CIT CASZ1 ARPC2 ARHGAP1 PCGF6 XIRP2 RBM19 SUN2 CNDP2 ZNF638 CCT8 PPP1R9B LIMCH1 HADHA FTO ATP2A2 PCCB RHOT1 | 3.44e-05 | 1445 | 136 | 24 | int:EED |
| Interaction | PCDHA4 interactions | 5.27e-05 | 60 | 136 | 5 | int:PCDHA4 | |
| Interaction | AGR2 interactions | ACLY SYNE1 WDR81 PCDHA8 CP ZZEF1 ARPC2 ARHGAP1 NBAS DST CNDP2 CCT8 C3 HADHA MYO15A SPAG17 ATP2A2 PCCB | 5.79e-05 | 934 | 136 | 18 | int:AGR2 |
| Interaction | FLT3 interactions | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TRRAP | 6.11e-05 | 318 | 136 | 10 | int:FLT3 |
| Interaction | LONP2 interactions | 6.18e-05 | 62 | 136 | 5 | int:LONP2 | |
| Interaction | TNIP1 interactions | UIMC1 MTHFD2 ACLY SYNE1 U2SURP MCM6 GPATCH4 XRCC1 SBSN ARPC2 CSDE1 DST ASS1 CCT8 GSDMA PPP1R9B C3 LIMCH1 HADHA ATP2A2 HSPB1 | 6.61e-05 | 1217 | 136 | 21 | int:TNIP1 |
| Interaction | PCDHA2 interactions | 1.04e-04 | 14 | 136 | 3 | int:PCDHA2 | |
| Interaction | NAA40 interactions | UIMC1 ACLY U2SURP RSF1 CKAP5 GPATCH4 CIT CSDE1 DST ZNF638 CCT8 PPP1R9B BOD1L1 LIMCH1 MTDH PKN3 EPB41L2 SOD1 | 1.04e-04 | 978 | 136 | 18 | int:NAA40 |
| Cytoband | 5q31 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.81e-11 | 115 | 139 | 9 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.55e-07 | 298 | 139 | 9 | chr5q31 |
| Cytoband | 12q24.21 | 9.05e-05 | 5 | 139 | 2 | 12q24.21 | |
| Cytoband | 10q26.2 | 5.89e-04 | 12 | 139 | 2 | 10q26.2 | |
| GeneFamily | Clustered protocadherins | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.04e-11 | 64 | 81 | 9 | 20 |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 1.18e-04 | 4 | 81 | 2 | 1163 | |
| GeneFamily | EF-hand domain containing | 4.49e-04 | 219 | 81 | 6 | 863 | |
| GeneFamily | LIM domain containing | 2.35e-03 | 59 | 81 | 3 | 1218 | |
| Coexpression | GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.20e-06 | 200 | 138 | 9 | M6975 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 DHDH | 1.31e-06 | 261 | 138 | 10 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA13 PCDHA12 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 DHDH | 5.01e-06 | 238 | 138 | 9 | M2020 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | U2SURP CKAP5 MED13L TRRAP DST ZNF638 LIMCH1 RPGR FTO FUT8 WWC1 RBFOX2 | 6.98e-06 | 466 | 138 | 12 | M13522 |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 1.14e-05 | 200 | 138 | 8 | M3390 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.14e-05 | 200 | 138 | 8 | M6477 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RASA3 ACLY KBTBD8 LAMB3 MED13L ZZEF1 KIAA1614 INPP4B ARPC2 ASS1 LIMCH1 ADAMTS14 FTO ATP2A2 PCCB SOD1 | 8.51e-05 | 1009 | 138 | 16 | M157 |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 8.60e-05 | 197 | 138 | 7 | M7403 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP | 9.16e-05 | 199 | 138 | 7 | M8318 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.16e-05 | 199 | 138 | 7 | M5893 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 9.16e-05 | 199 | 138 | 7 | M9124 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN | 9.45e-05 | 200 | 138 | 7 | M7473 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 9.45e-05 | 200 | 138 | 7 | M8956 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_UP | 9.45e-05 | 200 | 138 | 7 | M4471 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | KBTBD8 LAMB3 KIAA1614 ARPC2 ASS1 LIMCH1 ADAMTS14 ATP2A2 PCCB SOD1 | 1.13e-04 | 438 | 138 | 10 | M227 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | RASA3 LAMB3 MED13L ZZEF1 KIAA1614 INPP4B ARPC2 ASS1 LIMCH1 ADAMTS14 | 1.20e-04 | 441 | 138 | 10 | M172 |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | PCDHA8 CP PCDHA7 PCDHA3 MED13L KIAA1614 C17orf58 CD8B LIMCH1 | 2.36e-09 | 163 | 139 | 9 | f1ec2625b52664308968b01d8e0275e1e0751480 |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-07 | 195 | 139 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 198 | 139 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 198 | 139 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.18e-07 | 199 | 139 | 8 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-07 | 199 | 139 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.57e-07 | 161 | 139 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 182 | 139 | 7 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.06e-06 | 187 | 139 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-06 | 187 | 139 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 187 | 139 | 7 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 189 | 139 | 7 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 2.21e-06 | 189 | 139 | 7 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-06 | 194 | 139 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-06 | 197 | 139 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-06 | 198 | 139 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-06 | 200 | 139 | 7 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | medial-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-06 | 200 | 139 | 7 | 0079041c3e654c1ef77c492bdb2f31ce8f4b507b | |
| ToppCell | medial-Epithelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-06 | 200 | 139 | 7 | 17bb9a9016058cbb70c7bd894c12f6208ff07895 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.21e-06 | 200 | 139 | 7 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-05 | 169 | 139 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-05 | 172 | 139 | 6 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.92e-05 | 176 | 139 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 177 | 139 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-05 | 178 | 139 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.11e-05 | 179 | 139 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 181 | 139 | 6 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 184 | 139 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 184 | 139 | 6 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.47e-05 | 184 | 139 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 185 | 139 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-05 | 185 | 139 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-05 | 187 | 139 | 6 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | Club-club-14|World / Class top | 2.70e-05 | 187 | 139 | 6 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 188 | 139 | 6 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-05 | 189 | 139 | 6 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-05 | 189 | 139 | 6 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.95e-05 | 190 | 139 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.95e-05 | 190 | 139 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 191 | 139 | 6 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 3.04e-05 | 191 | 139 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 191 | 139 | 6 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-05 | 191 | 139 | 6 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-05 | 191 | 139 | 6 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 3.04e-05 | 191 | 139 | 6 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.13e-05 | 192 | 139 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.22e-05 | 193 | 139 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 194 | 139 | 6 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.32e-05 | 194 | 139 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.32e-05 | 194 | 139 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.42e-05 | 195 | 139 | 6 | be8db0a22ef8ce24819f790b0bd93670e73af76f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 195 | 139 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.42e-05 | 195 | 139 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.42e-05 | 195 | 139 | 6 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.42e-05 | 195 | 139 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 195 | 139 | 6 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-05 | 196 | 139 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-05 | 196 | 139 | 6 | 80264c2fbd94418f981085fed7c5bdda1e6f404c | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 197 | 139 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.62e-05 | 197 | 139 | 6 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 197 | 139 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 197 | 139 | 6 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | Epithelial_cells-Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.72e-05 | 198 | 139 | 6 | 52e9d41a1726bc1140df6baec9f17a534448ac8b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 198 | 139 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | distal-Epithelial-Club-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.72e-05 | 198 | 139 | 6 | 77c7fa7626ea35cb50de9c2f2df637d22e77d3fe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-05 | 198 | 139 | 6 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.72e-05 | 198 | 139 | 6 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-05 | 198 | 139 | 6 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.72e-05 | 198 | 139 | 6 | eeec789d226171f30799577cc37c07bdced2e3cb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.83e-05 | 199 | 139 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 199 | 139 | 6 | b44d74895846e2ac144438b73e0ca91e3949c16c | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 199 | 139 | 6 | 4b374a5de82b4614d3d8a00202ea6cb8f1fd8104 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|lymphoid / Lineage, cell class and subclass | 3.83e-05 | 199 | 139 | 6 | 22926327c93ede9f3408c99a0d56e373a33240ef | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.83e-05 | 199 | 139 | 6 | 9e8231c9007d8d963805a4c99e0905538ceb9b60 | |
| ToppCell | tumor_Lung-Epithelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.83e-05 | 199 | 139 | 6 | 56b3f6c8b561d60780d91daf6b44a9dcf616e599 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.93e-05 | 200 | 139 | 6 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.93e-05 | 200 | 139 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.93e-05 | 200 | 139 | 6 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.93e-05 | 200 | 139 | 6 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | control-cDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.93e-05 | 200 | 139 | 6 | 4a6d17a4225be38537d3dd8a39512051f597f4e0 | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA13 PCDHA12 PCDHA8 PCDHA7 MCM6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.91e-17 | 29 | 131 | 10 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NBAS | 6.29e-12 | 87 | 131 | 10 | EFO_0004340, EFO_0004765 |
| Disease | post-traumatic stress disorder symptom measurement | SYNE1 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MACROD2 | 1.13e-10 | 82 | 131 | 9 | EFO_0008535 |
| Disease | neutrophil count, basophil count | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.56e-07 | 224 | 131 | 9 | EFO_0004833, EFO_0005090 |
| Disease | neutrophil count | ATP13A1 KIF1B PCDHA13 PCDHA12 PCDHA8 PCDHA7 MCM6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 VWA7 CIT CASZ1 ARPC2 GSDMA FTO STK38L TNXB PKN3 | 7.84e-07 | 1382 | 131 | 21 | EFO_0004833 |
| Disease | vital capacity | SYNE1 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ZZEF1 CASZ1 DST CROCC2 ATP2A2 TNXB EPB41L2 PDZD2 | 9.36e-06 | 1236 | 131 | 18 | EFO_0004312 |
| Disease | type 2 diabetes mellitus (is_marker_for) | 3.35e-05 | 136 | 131 | 6 | DOID:9352 (is_marker_for) | |
| Disease | post-traumatic stress disorder | 3.46e-05 | 202 | 131 | 7 | EFO_0001358 | |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ZNF638 FTO | 4.68e-05 | 566 | 131 | 11 | EFO_0007660, EFO_0008354 |
| Disease | cortical surface area measurement | NCAPD3 DDAH1 NDUFAF2 KIF1B MED13L KIAA1614 C17orf58 ARHGAP1 PCGF6 MACROD2 PPP1R9B SPAG17 TNXB WWC1 RHOT1 TANGO6 PDZD2 | 9.85e-05 | 1345 | 131 | 17 | EFO_0010736 |
| Disease | Retinal Degeneration | 1.07e-04 | 21 | 131 | 3 | C0035304 | |
| Disease | Hepatitis, Chronic | 1.24e-04 | 22 | 131 | 3 | C0019189 | |
| Disease | Chronic active hepatitis | 1.24e-04 | 22 | 131 | 3 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 1.24e-04 | 22 | 131 | 3 | C0149519 | |
| Disease | Cryptogenic Chronic Hepatitis | 1.24e-04 | 22 | 131 | 3 | C0524611 | |
| Disease | Drug habituation | 1.66e-04 | 115 | 131 | 5 | C0013170 | |
| Disease | Drug abuse | 1.66e-04 | 115 | 131 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.66e-04 | 115 | 131 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.66e-04 | 115 | 131 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.66e-04 | 115 | 131 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.66e-04 | 115 | 131 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.66e-04 | 115 | 131 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.66e-04 | 115 | 131 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.66e-04 | 115 | 131 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.73e-04 | 116 | 131 | 5 | C0740858 | |
| Disease | hypertension (is_implicated_in) | 2.10e-04 | 121 | 131 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | Abnormality of refraction | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ZZEF1 CNDP2 | 2.14e-04 | 673 | 131 | 11 | HP_0000539 |
| Disease | Involuntary Movements | 4.05e-04 | 7 | 131 | 2 | C0427086 | |
| Disease | pulse pressure measurement | DDAH1 CKAP5 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MED13L CASZ1 ZNF638 FTO CFAP69 | 4.60e-04 | 1392 | 131 | 16 | EFO_0005763 |
| Disease | Moderate albuminuria, diabetic nephropathy | 5.38e-04 | 8 | 131 | 2 | EFO_0000401, HP_0012594 | |
| Disease | infection | 6.90e-04 | 9 | 131 | 2 | EFO_0000544 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 8.06e-04 | 41 | 131 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Carotid Circulation Transient Ischemic Attack | 8.60e-04 | 10 | 131 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 8.60e-04 | 10 | 131 | 2 | C0007787 | |
| Disease | Crescendo Transient Ischemic Attacks | 8.60e-04 | 10 | 131 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 8.60e-04 | 10 | 131 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 8.60e-04 | 10 | 131 | 2 | C0751022 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 8.60e-04 | 10 | 131 | 2 | C0472381 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 8.60e-04 | 10 | 131 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 8.60e-04 | 10 | 131 | 2 | C0917805 | |
| Disease | hearing impairment | 9.71e-04 | 98 | 131 | 4 | C1384666 | |
| Disease | myeloid white cell count | RASA3 ATP13A1 KIF1B MCM6 LRRK1 CIT KIAA1614 GSDMA C3 SPAG17 ATP2A2 PKN3 | 9.80e-04 | 937 | 131 | 12 | EFO_0007988 |
| Disease | triacylglycerol 56:2 measurement | 1.05e-03 | 11 | 131 | 2 | EFO_0010429 | |
| Disease | FEV/FEC ratio | U2SURP KIF1B TASP1 ITGAV INPP4B C17orf58 AGBL4 KIF3B DST CROCC2 RASGRP3 FTO MYO15A TNXB | 1.14e-03 | 1228 | 131 | 14 | EFO_0004713 |
| Disease | oncostatin-M measurement | 1.25e-03 | 12 | 131 | 2 | EFO_0010792 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.48e-03 | 13 | 131 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | N-acetyltaurine measurement | 1.48e-03 | 13 | 131 | 2 | EFO_0020023 | |
| Disease | Congestive heart failure | 1.49e-03 | 110 | 131 | 4 | C0018802 | |
| Disease | Heart failure | 1.49e-03 | 110 | 131 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.49e-03 | 110 | 131 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.49e-03 | 110 | 131 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.49e-03 | 110 | 131 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.49e-03 | 110 | 131 | 4 | C1959583 | |
| Disease | Acute Cerebrovascular Accidents | 1.80e-03 | 54 | 131 | 3 | C0751956 | |
| Disease | urate measurement, bone density | 1.82e-03 | 619 | 131 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Body Weight | 1.98e-03 | 15 | 131 | 2 | C0005910 | |
| Disease | neurofilament light chain measurement | 2.10e-03 | 57 | 131 | 3 | EFO_0009178 | |
| Disease | heart disease (biomarker_via_orthology) | 2.55e-03 | 17 | 131 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.55e-03 | 17 | 131 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | sex interaction measurement, ulcerative colitis | 2.55e-03 | 17 | 131 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.55e-03 | 17 | 131 | 2 | cv:C0270914 | |
| Disease | Cerebrovascular accident | 2.67e-03 | 62 | 131 | 3 | C0038454 | |
| Disease | cutaneous melanoma, hair color | 2.67e-03 | 62 | 131 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | essential hypertension (is_implicated_in) | 2.86e-03 | 18 | 131 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | neck circumference | 3.18e-03 | 19 | 131 | 2 | EFO_0011043 | |
| Disease | Ischemic stroke | 3.32e-03 | 324 | 131 | 6 | HP_0002140 | |
| Disease | sporadic amyotrophic lateral sclerosis | 3.57e-03 | 140 | 131 | 4 | EFO_0001357 | |
| Disease | bipolar I disorder | 3.66e-03 | 141 | 131 | 4 | EFO_0009963 | |
| Disease | chronic obstructive pulmonary disease | 3.68e-03 | 688 | 131 | 9 | EFO_0000341 | |
| Disease | cardiovascular system disease (is_implicated_in) | 3.89e-03 | 21 | 131 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | systemising measurement | 3.89e-03 | 21 | 131 | 2 | EFO_0010221 | |
| Disease | Intellectual Disability | 3.90e-03 | 447 | 131 | 7 | C3714756 | |
| Disease | body weight | COL16A1 KIZ PCDHA1 ZZEF1 AGBL4 NBAS RBM19 MACROD2 ZNF638 ADAMTS14 FTO EPB41L2 PDZD2 | 4.08e-03 | 1261 | 131 | 13 | EFO_0004338 |
| Disease | blood urea nitrogen measurement | 4.15e-03 | 452 | 131 | 7 | EFO_0004741 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.26e-03 | 22 | 131 | 2 | C3711387 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTVHAGEVGSAEVVK | 211 | P00813 | |
| FKVVRAGVHAPEEVG | 81 | Q96NT0 | |
| QVVVEKRADAGSHTE | 41 | Q86V15 | |
| AERGAKVHQETAADE | 301 | Q07092 | |
| TNDVGALKHADVGVA | 866 | Q9HD20 | |
| FQEEGKEGENRAVIH | 131 | O15144 | |
| GDVHEGFRTLKEEVQ | 251 | Q96QA5 | |
| DVKRHVLQVHEGGGE | 391 | Q9H116 | |
| EGDHGARVVLVAVDK | 586 | P01024 | |
| HVKEVQDGIELQAGD | 701 | O75534 | |
| EDAGEQVAQRHEEKV | 126 | Q9BSW2 | |
| EEEEKGGTHVNDVLN | 226 | Q9Y4B4 | |
| GHFAEVQVVREKATG | 106 | O14578 | |
| KVTDGFTQGHIVEVV | 736 | Q86XH1 | |
| EVAGKHGVGRIDIVE | 256 | P00966 | |
| ERGQQEKEASGRTHV | 191 | Q8WXS8 | |
| DHETKGSVAVRVALG | 541 | Q9Y4C8 | |
| KQVIAGVGALEQEHA | 781 | Q14644 | |
| KVEAENSEVRGHLGR | 631 | A6NNM3 | |
| KVEAENSEVRGHLGR | 631 | A6NJZ7 | |
| HGTVVEGRKIEVNNA | 181 | O43251 | |
| GVIQELEKGEAHREG | 381 | Q6ZSG2 | |
| EVRSGGTVVENGVHK | 181 | Q8IXS6 | |
| GAGHVVAKVRAVDAD | 586 | Q9Y5H9 | |
| GLTGQAEAREHAKET | 326 | Q5VVQ6 | |
| EVGDTIRVTFHNKGA | 456 | P00450 | |
| QDHGEIAKSESGRVL | 241 | Q5T089 | |
| GAGHVVAKVRAVDAD | 586 | Q9UN72 | |
| AGSQHLEVRDEVAEK | 11 | Q14566 | |
| GAGHVVAKVRAVDAD | 586 | Q9Y5H6 | |
| GAGHVVAKVRAVDAD | 586 | Q9Y5H8 | |
| VHEANGTEDERAVSK | 26 | P0CW19 | |
| VHEANGTEDERAVSK | 26 | P0CW20 | |
| LSVNGVSVEGEQHEK | 141 | Q9HAP6 | |
| GEDEALARHTGNVVI | 151 | Q8NES3 | |
| GGKVDEALVRSATVH | 1291 | Q71F56 | |
| IEVEAENGDGVIKSH | 96 | Q8NI17 | |
| IHEDEVAKTQKAEGG | 501 | Q8IX03 | |
| HGVLVDAAVVAKDTV | 1956 | Q38SD2 | |
| EQEELSKREVVAVGH | 1986 | Q9UKN7 | |
| RHLSIAQEQGDKVGE | 131 | Q86YR5 | |
| DGGKVDTSATHREVQ | 4001 | Q03001 | |
| EGVTNAVLHEVKREG | 411 | Q9C0B1 | |
| HRVAIVSEKGEVRGF | 991 | O60333 | |
| EFAVNGIVHDVDVLG | 211 | Q2M2W7 | |
| DGEADHITTDVQGQK | 191 | O15327 | |
| HHGQEGSILVTKVEE | 126 | Q9Y5P6 | |
| DDVEVENEVKEGRGH | 681 | Q5VZ46 | |
| KRIVITGDGDIDHDQ | 956 | O43491 | |
| EVGAGHSVNEETKAE | 26 | Q8N2X6 | |
| RHQEGKVSDEREGTT | 246 | Q5T3I0 | |
| NVVRKHISDGVADSG | 231 | Q8IXI2 | |
| IVVTQVKEGGAAHRD | 361 | O15018 | |
| QRKHVVFGSETGEGE | 796 | Q96JB1 | |
| TGVKITVVAGEHNIE | 271 | P00740 | |
| GVVEITGKHEERQDE | 116 | P04792 | |
| KDNHVVAAGGVEKAV | 171 | Q15274 | |
| ESEIHVVRGEGFKTV | 286 | Q05C16 | |
| GHVKDTNQEDGVIIS | 166 | Q9Y5B6 | |
| EEAKHGTFVGRIAQD | 36 | Q9Y5H7 | |
| EDREKVAVHEGINSG | 131 | Q2M2Z5 | |
| HGEKERQVSEAEENG | 176 | E9PIF3 | |
| EGVVAAVHASVDKGE | 2066 | A2RRP1 | |
| EKLDVTGNGHEEVVA | 311 | Q969R8 | |
| GQLTDIVVEVDHGKT | 46 | Q8NFY9 | |
| GAGHVVAKVRAVDAD | 586 | Q9Y5I3 | |
| GAGHVVAKVRAVDAD | 586 | Q9Y5I0 | |
| NEDVTQEELGGAKTH | 236 | P05166 | |
| GVGHVVAKVRAVDAD | 586 | Q9UN74 | |
| DGIAVDHVVGLNTEK | 1436 | Q8NFC6 | |
| GRKDNAEAISGHSVE | 2741 | Q8NFC6 | |
| TKTVEEVLGHFGVNE | 6 | P16615 | |
| VENAHVAGKTTGEVV | 76 | Q14008 | |
| AKGTIHGEEVEQEKI | 76 | A6NJW9 | |
| VDKASVRHGGENVAA | 46 | A1L0T0 | |
| AVVIHKGSDESEGER | 161 | Q8WZ55 | |
| KARHRAGTNQEEEEG | 211 | Q9P2K1 | |
| QRKLAEVEAAGEAHG | 1206 | H7BZ55 | |
| AKGTIHGEEVEQEKI | 76 | P10966 | |
| TEKNDTVAGQGERDH | 871 | P06756 | |
| EVVKEVVGHAKETGE | 116 | A8MYX2 | |
| EGAEQKVVFITGRVH | 216 | Q5VU57 | |
| KSLQGVAGVQDVEVH | 31 | O14618 | |
| EVEKGEGRLQTTHEE | 226 | A1A5D9 | |
| VQNSSRHDGKEVDEG | 176 | Q86UE4 | |
| KISVVGRRHETGVDD | 196 | Q9UQ10 | |
| TLVDEVGVDVAKHVA | 586 | P40939 | |
| QHEQRKEAGNIESGV | 226 | Q8N7U6 | |
| SRAHAVEGQVEDVVG | 971 | Q13751 | |
| ENHIQRKEIFGTEGV | 546 | A5D8W1 | |
| HEGKQLVNGEVSDER | 436 | Q96T23 | |
| QGAKEHEEAENITEG | 161 | Q9UHW9 | |
| SGITHAGREVEKVFN | 56 | Q6UWP8 | |
| QVGKEEDRVVQGLHH | 396 | Q6UWP8 | |
| GQHALRSAKGEEVDV | 26 | O94760 | |
| VDGKVSVNGETVHRE | 556 | Q9UPQ0 | |
| FVRVSGEATIGHVEK | 276 | Q9BYE7 | |
| GAGHVVAKVRAVDAD | 586 | Q9UN75 | |
| RLHVEAAVAEGAKNV | 186 | Q6P5Z2 | |
| TKGGEVTDHSVRDQD | 311 | A1Z1Q3 | |
| VEANEENVKVHGGRK | 811 | Q92834 | |
| GVHVRRTDKVGTEAA | 361 | Q9BYC5 | |
| ETGSREVVSHVIKQG | 51 | P32754 | |
| EHKVNIEDVATEGAG | 371 | P23975 | |
| ENRIGNSGVEEIKGH | 366 | Q9Y2H1 | |
| KGEAIDTANHGEVKR | 1151 | Q8NF91 | |
| DTANHGEVKRAVEEI | 1156 | Q8NF91 | |
| KEGAAVIDVGINRVH | 266 | P13995 | |
| KVEAENSEVRGHLGR | 631 | Q9UFD9 | |
| EKPRVHAGVDVVDRG | 656 | Q8IV61 | |
| DIARHQIVEVAGDDK | 66 | Q07960 | |
| QDEETGHGQRGSIKE | 446 | P23327 | |
| KDEERHVGDLGNVTA | 76 | P00441 | |
| VERKDGTRIVDHADG | 1441 | Q6Q759 | |
| VRGGVVNAAKEEHET | 136 | O15042 | |
| HEGGVDVGDVDAKAQ | 136 | P53396 | |
| QKVRGVDVVVGGHSN | 231 | P21589 | |
| IAEEHIQKVAIFGGT | 6 | P45381 | |
| EQELAKHADVAGTAG | 1266 | P42695 | |
| GINEAVAAVTEEEHK | 261 | Q96KP4 | |
| VGANQVTVRKGEKDH | 376 | Q96M02 | |
| EEKRVGTRTVFVGNH | 16 | Q8NB49 | |
| DASHKIEVEGVTRGA | 786 | A4UGR9 | |
| GSKIVSVGDDQEIHI | 286 | Q9GZS3 | |
| QKEGVIGVTEEQVHH | 516 | Q9UH99 | |
| SEVGLDGENHIRVGK | 226 | O15066 | |
| EHTVEGGEKQVVFTH | 61 | P22105 | |
| QKVSSEQGRVEHLGD | 566 | Q9C0B7 | |
| SREVKEHVGTDQFGN | 16 | Q8N183 | |
| VENETHGKIKNVIGE | 146 | O75635 | |
| QEEEEHGVKGVESVL | 46 | Q3C1V9 | |
| KEEQIHSVDIGNDGS | 51 | P18887 | |
| SEAGNGKRAVHEEIR | 2001 | O43149 | |
| AGQVARVVHITEDGQ | 1896 | Q9C0G0 | |
| GDTQVVVFKHEKEDG | 356 | P50990 | |
| GGEVIFTKDQHIRDV | 476 | Q9Y334 | |
| EVQVGKRSTEARHGV | 266 | O14939 | |
| GAVVVDHEGNVAAAV | 236 | Q9H6P5 | |
| EVVVITHKGGQRSDG | 1476 | Q9Y4A5 | |
| KGSHISQGNEAEERE | 166 | Q96RL1 | |
| KALEDVVQRSGHGTE | 576 | Q14966 | |
| AHEGDILQIKAVEGS | 1826 | Q562E7 | |
| DSGKIVINVGGVRHE | 86 | Q14003 | |
| GNVVGIVAARAHEED | 191 | Q8N9F0 | |
| IFVKTVTEGGAAHRD | 526 | Q96SB3 | |
| VHLVADGKFGTQERV | 476 | Q05586 |